Artificial Intelligence-Assisted Chest X-ray for the Diagnosis of COVID-19: A Systematic Review and Meta-Analysis.
I-Shiang TzengPo-Chun HsiehWen-Lin SuTsung-Han HsiehSheng-Chang ChangPublished in: Diagnostics (Basel, Switzerland) (2023)
Because it is an accessible and routine image test, medical personnel commonly use a chest X-ray for COVID-19 infections. Artificial intelligence (AI) is now widely applied to improve the precision of routine image tests. Hence, we investigated the clinical merit of the chest X-ray to detect COVID-19 when assisted by AI. We used PubMed, Cochrane Library, MedRxiv, ArXiv, and Embase to search for relevant research published between 1 January 2020 and 30 May 2022. We collected essays that dissected AI-based measures used for patients diagnosed with COVID-19 and excluded research lacking measurements using relevant parameters (i.e., sensitivity, specificity, and area under curve). Two independent researchers summarized the information, and discords were eliminated by consensus. A random effects model was used to calculate the pooled sensitivities and specificities. The sensitivity of the included research studies was enhanced by eliminating research with possible heterogeneity. A summary receiver operating characteristic curve (SROC) was generated to investigate the diagnostic value for detecting COVID-19 patients. Nine studies were recruited in this analysis, including 39,603 subjects. The pooled sensitivity and specificity were estimated as 0.9472 ( p = 0.0338, 95% CI 0.9009-0.9959) and 0.9610 ( p < 0.0001, 95% CI 0.9428-0.9795), respectively. The area under the SROC was 0.98 (95% CI 0.94-1.00). The heterogeneity of diagnostic odds ratio was presented in the recruited studies (I 2 = 36.212, p = 0.129). The AI-assisted chest X-ray scan for COVID-19 detection offered excellent diagnostic potential and broader application.
Keyphrases
- artificial intelligence
- sars cov
- coronavirus disease
- deep learning
- machine learning
- big data
- dual energy
- high resolution
- end stage renal disease
- respiratory syndrome coronavirus
- single cell
- healthcare
- chronic kidney disease
- computed tomography
- clinical practice
- ejection fraction
- case control
- systematic review
- newly diagnosed
- peritoneal dialysis
- magnetic resonance
- magnetic resonance imaging
- label free
- study protocol
- health information
- mass spectrometry
- patient reported outcomes
- open label
- single molecule